$ONCT

Oncternal Therapeutics Inc

  • NASDAQ
  • Biotechnology
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.8401 β–Ό-3.802%

Extented Hours

VOLUME

178,778

DAY RANGE

0.84 - 0.882

52 WEEK

0.5951 - 1.87

Join Discuss about ONCT with like-minded investors

profile
@Chano #StockTraders.NET
recently

tanking city $HJLI $SLS $ GLSI $ONCT

85 Replies 13 πŸ‘ 7 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

$ONCT what was that trend lol

48 Replies 15 πŸ‘ 6 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

covered some $ONCT didnt crack today

99 Replies 13 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$onct dropped an offering

133 Replies 13 πŸ‘ 6 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT F'in hell

137 Replies 11 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

wow $ONCT tomorrow might be the day for the short

76 Replies 10 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT continuing higher

74 Replies 15 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ONCT is starting to go along with $NURO

46 Replies 11 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

but tmepted to short $ONCT lol

49 Replies 13 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

would be ncie if $ONCT could go higher might re hit it

60 Replies 7 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

all covered $ONCT

142 Replies 13 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some more $ONCT

144 Replies 13 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT If I was shorting would cover and move on

150 Replies 7 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covering some small here on $Onct but will add back on any nice pops $4.14

74 Replies 11 πŸ‘ 9 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

@maletone fingers crossed for yor $ONCT short

150 Replies 14 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ONCT needs to take out this $4.20 area to the downside

140 Replies 13 πŸ‘ 6 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

πŸ‘‡ > @TraderXx said: $ONCT 4.20's o/u key lvl

95 Replies 8 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT 4.20's o/u key lvl

126 Replies 8 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

nice fail on $ONCT just need it under vwap

54 Replies 9 πŸ‘ 12 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

the only thing about $ONCT is that it is a Bio, so could be much trickier

84 Replies 7 πŸ‘ 6 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT chart carbon copy $PPSI on Friday

122 Replies 7 πŸ‘ 10 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

re hit some $ONCT

82 Replies 14 πŸ‘ 14 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

stopped out of $ONCT will rehit higher

90 Replies 14 πŸ‘ 9 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

added $ONCT

109 Replies 12 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

added back some shorts on $ONCT

130 Replies 8 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some $ONCT will revist

80 Replies 9 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

added some short small $ONCT but will wait for higher

112 Replies 15 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

might add back some covers on $ONCT

123 Replies 15 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some $BCRX and some $ONCT

132 Replies 11 πŸ‘ 12 πŸ”₯

profile
@Armm5 #StockTraders.NET
recently

$ONCT love it

89 Replies 7 πŸ‘ 12 πŸ”₯

profile
@maletone #StockTraders.NET
recently

I'm in some $ONCT and muight add too

137 Replies 15 πŸ‘ 6 πŸ”₯

profile
@Math #StockTraders.NET
recently

$ONCT warrants unregistered...

119 Replies 13 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

i think $ONCT has a presentation coming up

87 Replies 14 πŸ‘ 10 πŸ”₯

profile
@Armm5 #StockTraders.NET
recently

$ONCT will dump- warrants

69 Replies 12 πŸ‘ 15 πŸ”₯

AN
@Anthonypasquale #LWT Trading
recently

Damn. Sold $ONCT basically at the bottom. in @3.38, hit loss limit @ 3.25. now its at 3.71. gotta give it more space.

139 Replies 9 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ONCT lets do it

43 Replies 13 πŸ‘ 8 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT volume'less POS moving

103 Replies 9 πŸ‘ 7 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT came right back down, short were like, F this am out

97 Replies 9 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT smart asses

117 Replies 11 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ONCT all covered 5.28

135 Replies 11 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

Oncternal Therapeutics to Present at Stifel Virtual Healthcare ConferenceΒ ONCTΒ 

70 Replies 11 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covering some $ONCT here 5.02

128 Replies 10 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

waiting on $ONCT to crack 5's

61 Replies 12 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ONCT would love to see something stupid

146 Replies 10 πŸ‘ 10 πŸ”₯

profile
@maletone #StockTraders.NET
recently

I had orders on $ONCT in the 7's that never got hit just cancelled

148 Replies 14 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

looking to cover some $ONCT in the 4.90's

54 Replies 7 πŸ‘ 6 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

covered $ONCT here

138 Replies 10 πŸ‘ 10 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

$ONCT nice as well

75 Replies 12 πŸ‘ 10 πŸ”₯

profile
@viking #StockTraders.NET
recently

covered $ONCT. adding back on pop

100 Replies 7 πŸ‘ 11 πŸ”₯

Key Metrics

Market Cap

51.27 M

Beta

1.32

Avg. Volume

302.24 K

Shares Outstanding

58.71 M

Yield

0%

Public Float

0

Next Earnings Date

2023-05-04

Next Dividend Date

Company Information

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation or progression. The clinical pipeline includes cirmtuzumab, an investigational monoclonal antibody designed to inhibit the ROR1 pathway, a type I tyrosine kinase-like orphan receptor, that is being evaluated in a Phase 1/2 clinical trial in combination with ibrutinib for the treatment of patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) and in an investigator-sponsored, Phase 1b clinical trial in combination with paclitaxel for the treatment of women with HER2-negative metastatic or locally advanced, unresectable breast cancer. The clinical pipeline also includes TK216, an investigational targeted small-molecule inhibitor of the ETS family of oncoproteins, that is being evaluated in a Phase 1 clinical trial for patients with Ewing sarcoma alone and in combination with vincristine chemotherapy. In addition, Oncternal has a program utilizing the cirmtuzumab antibody backbone to develop a CAR-T therapy that targets ROR1, which is currently in preclinical development as a potential treatment for hematologic cancers and solid tumors.

CEO: James Breitmeyer

Website:

HQ: 12230 El Camino Real Ste 300 San Diego, 92130-2090 California

Related News